109 related articles for article (PubMed ID: 12124412)
1. Genetic control of bone remodeling--insights from a rare disease.
Krane SM
N Engl J Med; 2002 Jul; 347(3):210-2. PubMed ID: 12124412
[No Abstract] [Full Text] [Related]
2. Osteoprotegerin deficiency and juvenile Paget's disease.
Whyte MP; Obrecht SE; Finnegan PM; Jones JL; Podgornik MN; McAlister WH; Mumm S
N Engl J Med; 2002 Jul; 347(3):175-84. PubMed ID: 12124406
[TBL] [Abstract][Full Text] [Related]
3. Osteoprotegerin deficiency and juvenile Paget's disease.
Hofbauer LC; Schoppet M
N Engl J Med; 2002 Nov; 347(20):1622-3; author reply 1622-3. PubMed ID: 12432053
[No Abstract] [Full Text] [Related]
4. [Possible role of RANKL in bone resorption].
Udagawa N; Nakamura M; Takahashi N
Nihon Rinsho; 2004 Feb; 62 Suppl 2():97-101. PubMed ID: 15035104
[No Abstract] [Full Text] [Related]
5. The genetics of Paget's disease of the bone.
Leach RJ; Singer FR; Roodman GD
J Clin Endocrinol Metab; 2001 Jan; 86(1):24-8. PubMed ID: 11231972
[No Abstract] [Full Text] [Related]
6. Paget's disease of bone and genetic disorders of RANKL/OPG/RANK/NF-kappaB signaling.
Whyte MP
Ann N Y Acad Sci; 2006 Apr; 1068():143-64. PubMed ID: 16831914
[TBL] [Abstract][Full Text] [Related]
7. Loss of chaotic trabecular structure in OPG-deficient juvenile Paget's disease patients indicates a chaogenic role for OPG in nonlinear pattern formation of trabecular bone.
Salmon P
J Bone Miner Res; 2004 May; 19(5):695-702. PubMed ID: 15068491
[TBL] [Abstract][Full Text] [Related]
8. Deletion of aspartate 182 in OPG causes juvenile Paget's disease by impairing both protein secretion and binding to RANKL.
Middleton-Hardie C; Zhu Q; Cundy H; Lin JM; Callon K; Tong PC; Xu J; Grey A; Cornish J; Naot D
J Bone Miner Res; 2006 Mar; 21(3):438-45. PubMed ID: 16491292
[TBL] [Abstract][Full Text] [Related]
9. [Bone Paget's disease in the young adult].
Collantes Estévez E; González Domínguez J
Rev Clin Esp; 2004 Oct; 204(10):505-6. PubMed ID: 15456600
[No Abstract] [Full Text] [Related]
10. [Osteoprotegrin and RANKL/RANK system: is it the future of bone metabolism?].
Ferrer Cañabate J; Tovar I; Martínez P
An Med Interna; 2002 Aug; 19(8):385-88. PubMed ID: 12244784
[No Abstract] [Full Text] [Related]
11. [Adhesion molecules in the context with bone remodeling and osteoporosis].
Tanaka Y
Nihon Rinsho; 2004 Feb; 62 Suppl 2():125-30. PubMed ID: 15035110
[No Abstract] [Full Text] [Related]
12. [The pathophysiology of osteoporosis/osteopenia in gene mutant mice].
Kobayashi Y; Takahashi N
Clin Calcium; 2006 Feb; 16(2):311-18. PubMed ID: 16465035
[TBL] [Abstract][Full Text] [Related]
13. [Recent advances in the regulation of bone remodeling].
Matsumoto T
Nihon Rinsho; 2004 Feb; 62 Suppl 2():37-46. PubMed ID: 15035093
[No Abstract] [Full Text] [Related]
14. Bone stromal cells in pagetic bone and Paget's sarcoma express RANKL and support human osteoclast formation.
Sun SG; Lau YS; Itonaga I; Sabokbar A; Athanasou NA
J Pathol; 2006 May; 209(1):114-20. PubMed ID: 16482498
[TBL] [Abstract][Full Text] [Related]
15. [Effects of gravity on the gene expression of osteoclast differentiation factor and osteoclastogenesis inhibitory factor].
Kanematsu M; Takai H; Fujita Y; Sato A
Biol Sci Space; 1999 Sep; 13(3):140-1. PubMed ID: 12532992
[No Abstract] [Full Text] [Related]
16. The ratio of messenger RNA levels of receptor activator of nuclear factor kappaB ligand to osteoprotegerin correlates with bone remodeling indices in normal human cancellous bone but not in osteoarthritis.
Fazzalari NL; Kuliwaba JS; Atkins GJ; Forwood MR; Findlay DM
J Bone Miner Res; 2001 Jun; 16(6):1015-27. PubMed ID: 11393778
[TBL] [Abstract][Full Text] [Related]
17. [Osteoprotegerin ligand and osteoprotegerin: new concepts of the pathogenesis and therapy of metabolic bone diseases].
Hofbauer LC; Heufelder AE
Dtsch Med Wochenschr; 2001 Feb; 126(6):145-50. PubMed ID: 11233883
[No Abstract] [Full Text] [Related]
18. Injections of osteoprotegerin and PMA delay tooth eruption.
Wise GE; Yao S; Liu D
Clin Anat; 2006 Jan; 19(1):19-24. PubMed ID: 16283633
[TBL] [Abstract][Full Text] [Related]
19. Osteoprotegrin knockout mice demonstrate abnormal remodeling of the otic capsule and progressive hearing loss.
Zehnder AF; Kristiansen AG; Adams JC; Kujawa SG; Merchant SN; McKenna MJ
Laryngoscope; 2006 Feb; 116(2):201-6. PubMed ID: 16467704
[TBL] [Abstract][Full Text] [Related]
20. Idiopathic hyperphosphatasia and TNFRSF11B mutations: relationships between phenotype and genotype.
Chong B; Hegde M; Fawkner M; Simonet S; Cassinelli H; Coker M; Kanis J; Seidel J; Tau C; Tüysüz B; Yüksel B; Love D;
J Bone Miner Res; 2003 Dec; 18(12):2095-104. PubMed ID: 14672344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
